The store will not work correctly when cookies are disabled.
1-(4-(4-(pyrrolidin-1-yl)piperidin-1-yl)phenethyl)pyrrolidin-3-one
ID: ALA3134143
Chembl Id: CHEMBL3134143
PubChem CID: 76336636
Max Phase: Preclinical
Molecular Formula: C21H31N3O
Molecular Weight: 341.50
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCN(CCc2ccc(N3CCC(N4CCCC4)CC3)cc2)C1
Standard InChI: InChI=1S/C21H31N3O/c25-21-10-14-22(17-21)13-7-18-3-5-19(6-4-18)24-15-8-20(9-16-24)23-11-1-2-12-23/h3-6,20H,1-2,7-17H2
Standard InChI Key: XPRMMXSSYNEQNJ-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.50 | Molecular Weight (Monoisotopic): 341.2467 | AlogP: 2.57 | #Rotatable Bonds: 5 |
Polar Surface Area: 26.79 | Molecular Species: BASE | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.09 | CX LogP: 2.49 | CX LogD: -0.16 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.82 | Np Likeness Score: -0.96 |
References
1. Camerino MA, Zhong N, Dong A, Dickson BM, James LI, Baughman BM, Norris JL, Kireev DB, Janzen WP, Arrowsmith CH, Frye SV.. (2013) The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface., 4 (11): [PMID:24466405] [10.1039/c3md00197k] |